Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon

143 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading CRO in preclinical research with cutting-edge humanized mouse models for drug development. TransCure bioServices, a Taconic Biosciences company Rethinking preclinical research with your goals in mind. TransCure bioServices accelerates drug development by delivering the right humanized models, the right data, and the right partnership mindset. As part of Taconic Biosciences, a global leader in genetically engineered and humanized mouse models, we offer a fully integrated translational research platform, combining world-class models with advanced in vivo preclinical services. Our humanized mouse platforms generate robust, translatable in vivo data to support critical decision-making in: - Oncology (Human CDX, Human PDX, Syngeneic …

48 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Creative Technologies for Efficient Therapeutics, Precision medicine Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases. Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient. Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, …

89 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, Chemical process research, DMPK, and ADME

81 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

An expert team helping biotechs bring their drugs to and through clinical trials as efficiently as possible. Your expert team from concept to clinic. At Leads to Development, we use our knowledge and expertise to help biotechs bring their drugs to and through clinical trials as efficiently as possible, delivering value for companies and life-changing outcomes for patients. With decades of experience, more than 180 projects under our belt throughout Europe and the US, and a 100% success rate in obtaining clinic trial authorisations, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

#BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid

329 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue …

54 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery

131 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

268 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the …

176 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ultimate predictability Since 1999, genOway aims at bridging the gap between preclinical findings and clinical success with advanced, genetically engineered preclinical models and solutions. From customized mice and rats to ready-to-use cell lines, our solutions provide increased predictability and accelerate therapeutic breakthroughs. We work with 17 of the world’s Top pharma companies—as well as leading biotech firms, CROs, and academic institutions. At the heart of genOway is a team of 150+ skilled professionals, from 17 nationalities, all committed to advancing preclinical research. What We Offer • A catalogue of validated, ready-to-use mice and cell lines—developed in partnership with biopharma leaders …

45 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

98 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Driving innovation beyond convention We believe that science-powered innovation creates possibilities. As a privately held, fully-integrated global company, Revance is passionately driven by that philosophy in everything we do. Dedicated to offering a diverse portfolio in aesthetics, skincare, and therapeutics, our science-backed products care for individuals across the generations. By driving innovation beyond convention, we continue to research and develop differentiated products for health, beauty, and wellness. Botulinum Toxin, biotechnology, biotech, healthcare, science, and research

59 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and …

120 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

91 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Dermatological R&D and Testing Who we are A Contract Research Organization providing customized R&D, Testing, Regulatory and Consulting services to the Personal Care, Pharmaceutical, Medical Devices and Food Supplements industries. Our goal is to be in the scientific research vanguard, promoting the development of innovative products that meet both regulatory demands and consumers’ needs. What we do We provide a broad range of services worldwide from formulation development, to stability, safety, efficacy and consumer testing, as well as regulatory affairs, for the creation of fully customized, innovative, stable, safe, effective and regulatory compliant products for smaller to larger global brands. …

58 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Translating genetic discoveries into safe and effective treatments. Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with …

104 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

94 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are …

102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Redefining the future of drug development with a non-conventional biopharmaceutical model Landmark BioVentures is an integrative corporate and drug development company using resources smartly to advance multiple innovative therapies. Anchored by foundational science, LBV uncovers hidden gems with unrealized therapeutic potential by connecting non-obvious dots and taking a strategically-focused active hands-on approach with each nexus company. Led by a seasoned multidisciplinary team of drug developers, entrepreneurs and deal makers, LBV harnesses its specialized and industry-relevant drug development expertise and opportunistic and creative deal-making in resource-constrained environments, to streamline drug development, focusing on holistic value creation and capture. drug development , …

136 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Inspired by nature - realized by science 🍏 Inspired by nature – Realized by science Designing ideas for added value In the fast-moving cosmetic industry, innovation is the most important factor as it enables us to deliver new claims, new efficacy tests, new applications, new biochemical findings, as well as new marketing and communication tools to effectively differentiate products. At Mibelle Biochemistry, our mission is to design the most innovative actives for our customers. Inspired by nature – realized by science Our scientists transform naturally derived plant compounds into truly functional bioactive cosmetic ingredients. Our R&D team makes use of …

39 similar entities Type: SMB Activities: cosmetics deeptech Technologies: Synthetic Biology

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. …

149 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Genewity is a biotech company developing autologous cell and gene therapies.

306 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

69 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Fueled by Connections to Transform Rare DiseasesTM Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect patients’ priorities. Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/ Biopharmaceuticals, Cellular Metabolism, and Rare …

61 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Unlocking the full potential of genetic medicines. At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization …

62 similar entities Type: Incubators & VCs Startup Activities: biotech deeptech Technologies: Synthetic Biology

As of October, 2022, Forma Therapeutics has been acquired by Novo Nordisk.

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics …

153 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

44 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

167 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over …

48 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

One Life One Skin Skin Tech Pharma Group SLU is specialized in high-quality manufacturing of medical devices (Class II and III), injectables and peelings as well as advanced cosmeceuticals. Founded by Dr. Philippe Deprez in 1994, the company is dedicated to innovation, developing unique formulations through its internal R&D. With more than 30 years of expertise in aesthetic medicine, Skin Tech Pharma Group has established itself as a global player in the aesthetic market, with its brands available in more than 70 countries. The company's commitment to meeting diverse market needs has driven its expansion into the pharmaceutical sector, broadening …

57 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Giving Life to Science PureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders. For more information, visit www.puretechhealth.com or connect with us …

90 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across …

40 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

70 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences

220 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is …

148 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

162 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Contract research organization with commitment to quality data and quality support. Let's Discover Together. Reaction Biology specializes in answering your complex scientific questions to accelerate the development of your breakthrough therapeutic candidates. For over 20 years, leading pharmaceutical, academic, and biotech organizations worldwide have relied on our labs as the partner of choice to advance their most promising drug candidates and research pipelines. Our track record speaks for itself: we’ve served over 2,000 clients across more than 5,000 projects every year. We act as an extension of your team and operate with the speed, precision, and scientific rigor that you …

62 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos

162 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to …

88 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Changing lives with next generation peptide therapeutics At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases. Our …

60 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 35 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce …

17 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Advancing Cancer Treatment Breakthroughs Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3DTM bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization. Cancer research, 3D bioprinting , Cancer microenvironment, drug testing, oncology, assay services, oncology pre-clinical services, solid tumours, solid tumors, tumour microenvironment, tumor microenvironment, early phase drug development, and early drug discovery

186 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology